Changjiang Securities(SZ:000783) Mei Ri Jing Ji Xin Wen·2025-11-12 16:20Core Viewpoint - New Liyi Group, a major shareholder of Changjiang Securities, is conducting a stock pledge repurchase transaction involving approximately 411.67 million shares, which accounts for 7.44% of the total share capital of Changjiang Securities [2][4]. Share Pledge Details - The transaction consists of two parts: one pledge of about 290 million shares to Minqiong Limited, representing 35.18% of New Liyi Group's holdings and 5.24% of Changjiang Securities' total shares; and another pledge of approximately 122 million shares to Zhuang Bin Limited, representing 14.81% of New Liyi Group's holdings and 2.20% of the total shares [2][3]. - The total pledged shares represent about 50% of New Liyi Group's holdings in Changjiang Securities, which amounts to 823 million shares, or 14.89% of the total share capital [4]. Market Value of Pledged Shares - Based on the closing price of 8.93 yuan per share on the announcement date, the market value of the pledged shares is approximately 3.68 billion yuan [5]. Company Performance - For the first three quarters of 2025, Changjiang Securities reported total operating revenue of 8.49 billion yuan, a year-on-year increase of 76.66%, and a net profit attributable to shareholders of 3.37 billion yuan, up 135.20% year-on-year [8]. - In the third quarter alone, the company achieved operating revenue of 378.27 million yuan, reflecting a 94.04% increase compared to the same period last year, with a net profit of 163.57 million yuan, marking a 152.76% year-on-year growth [8]. Shareholder Background - New Liyi Group is led by Liu Yiqian, who is also a significant shareholder in other companies, including Hendi Pharmaceutical and the former listed company *ST Tianmao [6][7]. - Liu Yiqian's investment in Changjiang Securities began in 2015 when New Liyi Group acquired a 14.72% stake, becoming the largest shareholder [7].